Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ALBANY INTERNATIONAL CORP /DE/Financial_Report.xls
8-K/A - CURRENT REPORT - ALBANY INTERNATIONAL CORP /DE/e49191_8ka.htm
EX-99.9 - EFFECT OF CHANGES ON INCOME STATE FULL YEAR 2010 - ALBANY INTERNATIONAL CORP /DE/e49191ex99-9.htm
EX-99.2 - EFFECT OF CHANGES Q1 2012 - ALBANY INTERNATIONAL CORP /DE/e49191ex99-2.htm
EX-99.5 - EFFECT OF CHANGES FOR YEAR 2009 - ALBANY INTERNATIONAL CORP /DE/e49191ex99-5.htm
EX-99.7 - EFFECT OF CHANGES ON INCOME STATEMENT Q1 2012 - ALBANY INTERNATIONAL CORP /DE/e49191ex99-7.htm
EX-99.1 - EFFECT OF CHANGES FOR Q1 2011 - ALBANY INTERNATIONAL CORP /DE/e49191ex99-1.htm
EX-99.4 - EFFECT OF CHANGES FOR FULL YEAR 2010 - ALBANY INTERNATIONAL CORP /DE/e49191ex99-4.htm
EX-99.6 - EFFECT OF CHANGES ON INCOME STATEMENT Q1 2011 - ALBANY INTERNATIONAL CORP /DE/e49191ex99-6.htm
EX-99.3 - EFFECT OF CHANGES FOR FULL YEAR 2011 - ALBANY INTERNATIONAL CORP /DE/e49191ex99-3.htm
EX-99.10 - EFFECT OF CHANGES ON INCOME STATEMENT FULL YEAR 2009 - ALBANY INTERNATIONAL CORP /DE/e49191ex99-10.htm
EX-99.11 - EFFECT OF CHANGES ON BALANCE SHEETS MARCH 31, 2012 AND DECEMBER 31, 2011 - ALBANY INTERNATIONAL CORP /DE/e49191ex99-11.htm

99.8   Effect of changes on Income Statement for full year 2011 (000's, except for per share amounts).  
             
             
    As reported       Year ended
    Year ended   Reclassify Primaloft   December 31, 2011
    December 31,   to discontinued Other  reported in 
    2011   operations reclassifications 2012 format
             
Net sales   $814,696   ($27,409)   $787,287
Cost of goods sold   485,735   (12,614)   473,121
             
Gross profit   328,961   (14,795)                         -  314,166
   Selling, general, and administrative expenses   179,804   (5,409)   174,395
   Technical, product engineering, and research expenses 56,767   (921)   55,846
   Restructuring and other, net   9,317                                -    9,317
             
Operating income   83,073   (8,465) 74,608
   Interest expense, net   18,121                                 -    18,121
   Other (income)/expense, net   2,720                                 -                      (81) 2,639
             
Income before income taxes    62,232   (8,465) 81  53,848
   Income tax expense/(benefit)   35,779   (3,197)   32,582
             
Income from continuing operations before earnings of associated companies                          26,453                         (5,268)                      81                       21,266
Equity in (earnings)/losses from associated companies (81)                                 -                       81                                -
             
Income from continuing operations                          26,534                         (5,268)                         -                      21,266
             
   Income from operations of discontinued business   15,636   8,465    24,101
   Gain on sale of discontinued business                                   -                                 -                                  -
   Income tax expense on discontinued operations                            7,232                          3,197                         10,429
Income from discontinued operations                            8,404   5,268    13,672
Net income   $34,938    $                           -   $                     -  $34,938
             
Earnings per share - Basic            
(Loss)/income from continuing operations   $0.85       $0.68
Discontinued operations   0.27       0.44
Net (loss)/income   $1.12       $1.12
             
Earnings per share - Diluted            
(Loss)/income from continuing operations   $0.84       $0.67
Discontinued operations   0.27       $0.44
Net (loss)/income   $1.11       $1.11
             
Shares used in computing earnings per share:            
  Basic   31,262       31,262
  Diluted   31,510       31,510